Akebia Therapeutics, Inc. (AKBA) Q2 2025 Earnings Call Transcript
2025-08-07 19:34:09 ET
Akebia Therapeutics, Inc. (AKBA)
Q2 2025 Earnings Conference Call
August 07, 2025 08:00 AM ET
Company Participants
Erik John Ostrowski - Chief Business Officer, Senior VP, CFO & Treasurer
John P. Butler - CEO, President & Director
Mercedes Carrasco - Senior Director of Investor & Corporate Communications
Nicholas Grund - Senior VP & Chief Commercial Officer
Conference Call Participants
Julian Reed Harrison - BTIG, LLC, Research Division
Mazahir Lukman Alimohamed - Leerink Partners LLC, Research Division
Roger Song - Jefferies LLC, Research Division
Presentation
Operator
Good day and thank you for standing by. Welcome to the Akebia Second Quarter 2025 Financial Results. [Operator Instructions] Please be advised that today's call is being recorded....
Read the full article on Seeking Alpha
For further details see:
Akebia Therapeutics, Inc. (AKBA) Q2 2025 Earnings Call TranscriptNASDAQ: AKBA
AKBA Trading
-0.36% G/L:
$1.37 Last:
1,044,234 Volume:
$1.40 Open:



